#Pharmaceutical Acquisition
Explore articles tagged with Pharmaceutical Acquisition
Keeping Clinical Trials on Schedule
HRV Pharma's acquisition of Germany-based Phatebo expands its business into clinical trial supply and finished formulations. Phatebo provides investigational, comparator and ancillary medicines through licensed channels, with traceability of origin, batch and expiry to support reliable clinical trial operations.
A Foray Into European Markets
HRV Pharma is expanding into European markets through the planned acquisition of Germany-based Phatebo GmbH. The deal provides an entry into finished formulations, clinical trial supply and established pharmaceutical distribution capabilities, including a German wholesale authorisation and long-standing relationships with clinical trial sponsors.
Beyond APIs, Into Finished Formulations
HRV Pharma is expanding beyond APIs into finished formulations through its acquisition of a 100% equity stake in Germany-based Phatebo. The acquisition marks a significant step in HRV's growth, giving the company its first finished formulations business and a licensed operating presence in Germany, while opening new opportunities in the European pharmaceutical market.